Vetmedin CA1 Chewable Tablets (Pimobendan) - 5mg

Vetmedin CA1 Chewable Tablets - Heart Support for Dogs with MMVD

Vetmedin CA1 Chewable Tablets Pimobendan 5mg are a revolutionary treatment for dogs suffering from congestive heart failure (CHF), specifically targeting dilated cardiomyopathy (DCM) and chronic mitral valve disease (CMVD). 

Unlike conventional heart medications, Vetmedin CA1 works by enhancing cardiac output and dilating blood vessels. It reduces the heart's workload and improves overall heart function. This comprehensive solution is designed to significantly improve your dog's life, offering a potent and effective treatment for managing heart disease.

Prescription items are NON-RETURNABLE and NON-REFUNDABLE.

Please note that the product may arrive in a Hardy Paw Pharmacy vial, manufacturer packaging is shown for reference.

Benefits of Vetmedin CA1 Chewable Tablets

• Enhanced Heart Function: Pimobendan acts as an inodilator, increasing the efficiency of the heart's pumping action and expanding blood vessels to reduce the heart's workload.

• Improved Quality of Life: Dogs treated with Vetmedin CA1 show increased energy, reduced symptoms of heart failure, and prolonged survival times.

• Easy Administration: Chewable tablets make it simple to administer the correct dosage, avoiding the hassle of liquid medications or injections.

• Proven Efficacy: Supported by extensive veterinary research, Vetmedin CA1 is a trusted choice for managing CHF in dogs.

• Palatable Flavor: The chewable tablets are flavored to appeal to dogs, ensuring they take their medication willingly.

• Flexible Dosing: This can be given with or without food, offering flexibility in your dog's treatment regimen.

 Ingredients - Vetmedin Chewable Tablets 

• Primary Ingredient: Pimobendan 5mg

• Secondary Ingredients: Flavors, excipients, and binders to form the chewable tablet.

Vetmedin Dosage and Administration

Administer the tablet as prescribed by your veterinarian. The typical dosage is 0.23 mg/lb (0.5 mg/kg) body weight, divided into two doses.

Consistency

• Maintain a regular dosing schedule to ensure the best results. Administer the medication at the same times each day to maintain consistent blood levels of the medication.

Storage

• Store at room temperature away from moisture and light.

• Keep the tablets in their original packaging until use to maintain potency and prevent degradation.

Side Effects of Vetmedin CA1 Chewable Tablets

• Common Side Effects: Potential side effects may include loss of appetite, lethargy, diarrhea, and changes in heart rate.

• Rare Side Effects: In rare cases, vomiting or difficulty breathing may occur. If these symptoms persist, contact your veterinarian immediately.

Precautions

• For use only in dogs with preclinical MMVD that have a moderate or loud mitral murmur due to mitral regurgitation and cardiomegaly (Stage B2 MMVD, 2019 ACVIM Consensus Statement). A diagnosis of MMVD should be made using a comprehensive physical and cardiac examination which should include radiography and echocardiography.

• Stage B2 cardiomegaly is diagnosed based on meeting all three of the following criteria:

• Radiographic vertebral heart score (VHS) >10.5, and

• Echocardiographic left atrium/aorta ratio (LA/Ao ratio) ≥1.6, and

• Echocardiographic left ventricular internal diastolic diameter normalized to body weight (LVIDDN) ≥1.7.

• The echocardiographic examination is recommended in all cases to diagnose MMVD and confirm cardiomegaly. If therapy is initiated before the development of cardiomegaly, treated dogs are at risk for cardiac pathology associated with exaggerated hemodynamic responses to VETMEDIN-CA1.

• If only radiographic examination is possible, cardiomegaly may be diagnosed in cases where the VHS ≥11.5 and the vertebral left atrial size (VLAS) ≥3.01,2. If radiographic cardiomegaly does not meet both of these criteria, an echocardiogram should be performed before the initiation of therapy with VETMEDIN-CA1.

• VETMEDIN-CA1 has not been evaluated in dogs receiving concomitant heart medications.

• The safety of VETMEDIN-CA1 has not been established in dogs with asymptomatic heart disease caused by etiologies other than MMVD. The safe use of VETMEDIN-CA1 has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches.

Contraindications:

• Do not administer VETMEDIN-CA1 in cases of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons.

• Do not administer VETMEDIN-CA1 to dogs with Stage A or B1 preclinical MMVD (2019 ACVIM Consensus Statement) due to the risk of cardiac pathology associated with exaggerated hemodynamic responses to VETMEDIN-CA1.

Warnings

• Always follow your veterinarian's instructions regarding the use of Vetmedin CA1.

• Keep out of reach of children, and pets to prevent accidental ingestion.

Shipping & Returns 

• Shipping Policy: We offer all types of shipping options (Ground, Express, Priority, International) depending on the urgency of the product requirements. To know about our shipping policy in detail, click here.
• Refund policy: If you face any issue with our product and want to return it, read our refund policy carefully.

FAQs - Vetmedin CA1 Chewable Tablets 

1. What should I do if my dog accidentally ingests too many Vetmedin CA1 tablets?

If your dog accidentally ingests an overdose of Vetmedin CA1 tablets, contact your veterinarian or an emergency veterinary clinic immediately. Symptoms of overdose may include severe lethargy, vomiting, diarrhea, and increased heart rate.

2. How long does it take for Vetmedin CA1 to start working? 

Vetmedin CA1 generally begins to improve heart function within 1 to 2 hours of administration. Noticeable improvements in your dog's symptoms may be seen within a few days, but it may take a few weeks for full therapeutic effects.

3. Can Vetmedin CA1 be used in puppies or older dogs?

Vetmedin CA1 can be used in both puppies and older dogs. However, it is essential to consult with your veterinarian to determine the appropriate dosage and monitor for any potential side effects, especially in very young or senior dogs.

4. Are there any long-term effects of using Vetmedin CA1 in dogs?

Long-term use of Vetmedin CA1 is generally safe when prescribed by a veterinarian. Regular veterinary check-ups are important to monitor your dog’s heart condition and adjust dosages if necessary. Prolonged use can help manage symptoms of heart failure and improve quality of life.

5. Is there a need for routine blood tests while my dog is on Vetmedin CA1? 

Routine blood tests are not typically required for dogs on Vetmedin CA1 alone, but your veterinarian may recommend periodic check-ups and tests to monitor your dog’s heart health and overall condition, especially if they are on multiple medications.

Clinical Research: 

• https://www.fda.gov/animal-veterinary/cvm-updates/fda-conditionally-approves-first-drug-delay-onset-congestive-heart-failure-dogs
• https://www.drugs.com/vet/vetmedin-ca1-pimobendan-chewable-tablets.html